REX IncomeMax Option Strategy ETF (ULTI US) stock market data APIs
18.869
-1.08(-5.7%)
as of November 14, 2025
Try our APIs with
free plan!
REX IncomeMax Option Strategy ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
18.869
Open
17.7872
High
20.1719
Low
17.6548
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get REX IncomeMax Option Strategy ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
REX IncomeMax Option Strategy ETF News
New
Public Keys: Coinbase Cashes In, IBIT Slips, and REX Spins Volatility Into Gold
Public Keys is a weekly roundup from Decrypt that tracks the key publicly traded crypto companies. This week: Coinbase wallops Q3 estimates, BlackRock's IBIT sees a sharp pullback, and REX Shares' new...
Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development
Ultimovacs ASA TET platform shows efficient T cell priming and beneficial safety profile Data supported clinical transition to ongoing TENDU Phase I trial TET platform offers potential to strengthen ...
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
Ultimovacs ASA Oslo, 08 April 2022: In connection with the Annual General Meeting of Ultimovacs ASA to be held on 21 April 2022, Jónas Einarsson, Chair of the Board of Directors, has so far received...
Ultimovacs to host Investor Days 2022: Meet the Team
Ultimovacs ASA Oslo, 30 March 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, will host Investor Days 2022: Meet the Team events in ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
